Steady-state murine cDCs employ a number of mechanisms to limit viral infection, including constitutive basal expression of antiviral IFITM1/3 (90) and high level of expression of the thioesterase, PPT1, which protects steady state DCs from viral infection by promoting antigen degradation (112). This evidence concerns the gene IFITM1 and viral infectious disease.